As a cutting-edge modern biological technology, synthetic biology has risen to the commanding heights of national strategy, with increasing popularity and attention. In China's "14th Five-Year Plan" and the outline of long-term goals for 2035 - the "14th Five-Year Plan - Bioeconomy Development Plan", it is mentioned that it is necessary to accelerate the improvement of biotechnology innovation capabilities, promote the application of biodegradable material products, and aim at synthetic biology In cutting-edge fields such as science, we implement major national science and technology projects and key research and development plans. Various regions have also successively introduced plans and programs to support the synthetic biology industry, which undoubtedly provides good opportunities and environment for the development of synthetic biology companies.
The founding team of Jinran Biotechnology was fortunate enough to participate in the finals of the 2023 Innovation and Creativity Entrepreneurship Competition held by Nanjing University Business School MBA, "Nanda Partner", on April 8, and presented an exciting presentation titled "Preparation of Chiral Materials Based on Synthetic Biology" Report. After fierce competition, the competition finallyJinran biology team is in the bigracestand out,Won first prize. Today Ran Biotech can achieve such good results in the competition, which is inseparable from the concerted efforts and hard work of the entire team. At the same time, through this competition, the Jinran Biotech team has gained more confidence and greater motivation in the chiral pharmaceutical intermediates industry.
★Introduction to Jinran Biotechnology
Jinran Biotechnology was established in June 2020. It is a high-quality biomaterial green and intelligent manufacturing enterprise integrating R&D, production and sales. The company relies on the founding team's more than ten years of R&D and industrialization experience in synthetic biology and is committed to the design, R&D, production and sales of new chiral molecules and materials.
Currently, the company has 4 major technology platforms and 7 product pipelines, and is committed to helping humans realize their desire to create a better life through biosynthesis!
Jinran Biotechnology is committed toProvide high-quality chiral molecules and chiral materials to global customers, always upholdBiosynthesis creates value, to help human beings realize their desire to create a better life.
Post time: Apr-12-2023